Supplement use during an intergroup clinical trial for breast cancer (S0221).
Zirpoli GR; Brennan PM; Hong CC; McCann SE; Ciupak G; Davis W; Unger JM; Budd GT; Hershman DL; Moore HC; Stewart J; Isaacs C; Hobday T; Salim M; Hortobagyi GN; Gralow JR; Albain KS; Ambrosone CB; Breast Cancer Research And Treatment, 2013, vol. 137, issue 3, p 903, ISSN 15737217. ISBN 15737217.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef